| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kiora Pharmaceuticals Inc (KPRX) has 0 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. KPRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2024 | Stengone Carmine N. | Director | Buy | 1,250 | $3.68 | $4,600.00 | New | +1.7% | -24.6% | |
| Sep 10, 2024 | Shapiro Aron | Director | Buy | 3,000 | $3.60 | $10,800.00 | New | +0.6% | -22.6% | |
| Aug 19, 2024 | Walters-Hoffert Lisa51 | Director | Buy | 1,250 | $3.86 | $4,825.00 | New | -20.3% | -33.9% | |
| Aug 19, 2024 | Tyle Praveen | Director | Buy | 5,000 | $3.96 | $19,800.00 | +35,714% | -20.3% | -33.9% | |
| Aug 14, 2024 | Tosca Melissa | CFO | Buy | 2,000 | $3.21 | $6,420.00 | +17.2% | +16.8% | -18.4% | |
| Jun 14, 2024 | Tosca Melissa | EVP Finance | Buy | 100 | $5.25 | $525.00 | +2.6% | -32.5% | -43.7% | |
| Jun 14, 2024 | Daniels Eric Joseph | Chief Development Officer | Buy | 1,431 | $5.29 | $7,569.99 | +14.6% | -32.5% | -43.7% | |
| Jun 13, 2024 | Strem Brian M. | President And CEO | Buy | 3,000 | $5.00 | $14,997.00 | +26.0% | -26.0% | -37.6% | |
| Jun 13, 2024 | Parsons Erin | Director | Buy | 5,260 | $4.88 | $25,668.80 | New | -26.0% | -37.6% | |
| Nov 18, 2021 | Strem Brian M. | President And CEO | Buy | 17,853 | $1.41 | $25,172.73 | +187.6% | -48.0% | -93.1% |